Off-Label Use of GLP-1s for Addiction episode artwork

EPISODE · Apr 27, 2026 · 18 MIN

Off-Label Use of GLP-1s for Addiction

from The Recovery Playbook: Conversations about Addiction & Recovery · host The Menninger Clinic

Hunger quiets, cravings fade, and the conversation around recovery shifts when biology finally meets behavior. We unpack GLP-1 receptor agonists—how they signal fullness early, slow gastric emptying, and may unexpectedly lower alcohol intake and even smoking—through personal experience and fresh science. Ryan shares how a weekly injection moved his A1C from prediabetic to optimal without losing strength or ditching the gym, while also softening the pull of old addictive patterns. Dr. Daryl Shorter explains why these drugs, approved for type 2 diabetes and obesity, are generating buzz well beyond weight loss, and how they challenge the willpower-only model that has long fueled shame around food and substance use.We break down a recent phase 2, placebo-controlled trial of low-dose semaglutide that showed reduced alcohol self-administration, lower cravings, and fewer drinks per drinking day, with a bonus signal on smoking. Then we get practical: what responsible, off-label consideration looks like; why first-line treatments and therapy still matter; and how to weigh lawsuits, side effects, and costs against the reality of stalled recovery. The goal isn’t hype—it’s clarity. For some, GLP-1s may be a bridge to consistent habits, social meals without overeating, and a quieter mind around alcohol. For others, the risks or lack of indication mean they’re not the right fit.We also look ahead to oral formulations in development and a care model where metabolic health, psychiatry, and recovery intersect. If you’re curious whether biology-informed tools can make change stick, this conversation offers nuance, guardrails, and hope. Listen, reflect, and share with someone who’s weighing their options. If this resonated, follow the show, leave a review, and tell us: could GLP-1s be a game changer in your recovery toolkit?Follow The Menninger Clinic on Twitter, Facebook, Instagram and LinkedIn to stay up to date on new Recovery Playbook episodes with Ryan Leaf and Daryl Shorter, M.D.  To submit a topic for discussion, email [email protected]. If you are a new or regular listener, please leave us a review on your favorite listening platform! Visit www.menningerclinic.org to learn more about The Menninger Clinic’s research and leadership role in mental health.

NOW PLAYING

Off-Label Use of GLP-1s for Addiction

0:00 18:06

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Recovery Playbook: Conversations about Addiction & Recovery?

This episode is 18 minutes long.

When was this The Recovery Playbook: Conversations about Addiction & Recovery episode published?

This episode was published on April 27, 2026.

What is this episode about?

Hunger quiets, cravings fade, and the conversation around recovery shifts when biology finally meets behavior. We unpack GLP-1 receptor agonists—how they signal fullness early, slow gastric emptying, and may unexpectedly lower alcohol intake and...

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this The Recovery Playbook: Conversations about Addiction & Recovery episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!